vs
Side-by-side financial comparison of Fulgent Genetics, Inc. (FLGT) and OR Royalties Inc. (OR). Click either name above to swap in a different company.
Fulgent Genetics, Inc. is the larger business by last-quarter revenue ($71.1M vs $46.7M, roughly 1.5× OR Royalties Inc.).
Fulgent Genetics, Inc. is a molecular diagnostics technology firm that develops and offers genetic testing services including carrier screening, oncology testing, infectious disease detection, and hereditary condition analysis, serving clinical providers, pharma firms, research institutions and public health groups primarily in North America.
OR Royalties Inc. is a Canadian company that holds royalties in gold, silver and diamond mines, principally in the form of net smelter returns and streams.Like its predecessor company, Osisko Mining, it is headquartered in Montreal, Quebec, with shares listed on the Toronto Stock Exchange and the New York Stock Exchange.
FLGT vs OR — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2022
| Metric | | |
|---|---|---|
| Revenue | $71.1M | $46.7M |
| Net Profit | — | — |
| Gross Margin | 30.2% | — |
| Operating Margin | 21.1% | — |
| Net Margin | — | — |
| Revenue YoY | -3.2% | — |
| Net Profit YoY | — | — |
| EPS (diluted) | $0.04 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $71.1M | — | ||
| Q4 25 | $83.3M | — | ||
| Q3 25 | $84.1M | — | ||
| Q2 25 | $81.8M | — | ||
| Q1 25 | $73.5M | — | ||
| Q4 24 | $76.2M | — | ||
| Q3 24 | $71.7M | — | ||
| Q2 24 | $71.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | $-23.4M | — | ||
| Q3 25 | $-6.6M | — | ||
| Q2 25 | $-19.0M | — | ||
| Q1 25 | $-11.5M | — | ||
| Q4 24 | $-5.9M | — | ||
| Q3 24 | $-14.6M | — | ||
| Q2 24 | $-8.7M | — |
| Q1 26 | 30.2% | — | ||
| Q4 25 | 39.1% | — | ||
| Q3 25 | 42.2% | — | ||
| Q2 25 | 42.1% | — | ||
| Q1 25 | 38.6% | — | ||
| Q4 24 | 41.8% | — | ||
| Q3 24 | 37.3% | — | ||
| Q2 24 | 37.3% | — |
| Q1 26 | 21.1% | — | ||
| Q4 25 | -43.5% | — | ||
| Q3 25 | -18.3% | — | ||
| Q2 25 | -24.1% | — | ||
| Q1 25 | -26.9% | — | ||
| Q4 24 | -21.2% | — | ||
| Q3 24 | -23.8% | — | ||
| Q2 24 | -26.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | -28.1% | — | ||
| Q3 25 | -7.9% | — | ||
| Q2 25 | -23.2% | — | ||
| Q1 25 | -15.7% | — | ||
| Q4 24 | -7.7% | — | ||
| Q3 24 | -20.4% | — | ||
| Q2 24 | -12.3% | — |
| Q1 26 | $0.04 | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $23.4M | — |
| Total DebtLower is stronger | — | $222.8M |
| Stockholders' EquityBook value | — | $1.3B |
| Total Assets | $1.2B | — |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $23.4M | — | ||
| Q4 25 | $50.2M | — | ||
| Q3 25 | $117.6M | — | ||
| Q2 25 | $87.9M | — | ||
| Q1 25 | $67.3M | — | ||
| Q4 24 | $55.1M | — | ||
| Q3 24 | $58.0M | — | ||
| Q2 24 | $65.1M | — |
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.1B | — |
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | $1.2B | — | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $1.2B | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
